Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.
about
Pathogenesis of human immunodeficiency virus infectionVariability of human immunodeficiency virus type 1 group O strains isolated from Cameroonian patients living in FranceControlling the HIV/AIDS epidemic: current status and global challengesComparative immunogenicity of subtype a Human Immunodeficiency Virus type 1 envelope exhibiting differential exposure of conserved neutralization epitopesResistance of native, oligomeric envelope on simian immunodeficiency virus to digestion by glycosidases.Envelope deglycosylation enhances antigenicity of HIV-1 gp41 epitopes for both broad neutralizing antibodies and their unmutated ancestor antibodies.Potent intratype neutralizing activity distinguishes human immunodeficiency virus type 2 (HIV-2) from HIV-1Single amino acid substitution in constant region 1 or 4 of gp120 causes the phenotype of a human immunodeficiency virus type 1 variant with mutations in hypervariable regions 1 and 2 to revertRemoval of a single N-linked glycan in human immunodeficiency virus type 1 gp120 results in an enhanced ability to induce neutralizing antibody responsesNeutralization sensitivity of human immunodeficiency virus type 1 is determined in part by the cell in which the virus is propagated.Specificity of antibodies produced against native or desialylated human immunodeficiency virus type 1 recombinant gp160.Complement-mediated binding of naturally glycosylated and glycosylation-modified human immunodeficiency virus type 1 to human CR2 (CD21).Effects of L- and D-REKR amino acid-containing peptides on HIV and SIV envelope glycoprotein precursor maturation and HIV and SIV replication.
P2860
Q24634681-F59521EF-3DEE-4662-8D51-3B42F1731480Q30417537-B7813F35-5269-4C76-8F29-D2979F1B587AQ30420558-4EFE575B-A826-45C6-B5FD-99238E6B4515Q33648910-95263433-6500-43D8-9686-F4491DD738D5Q33827027-E1A68566-C6F0-44EC-BBFB-175522755358Q34016211-14BF2EB3-416A-4773-8C37-912F7CBAFCFEQ35665921-66A99630-4347-41D4-BC7B-266C393D2931Q35853972-4B6C3EFB-C074-4A2F-BA5E-29317C5B2336Q36424574-EC3E285E-CB39-4027-A206-26152DCBAD4AQ36628256-137C2E1B-2002-43D4-A16A-7E9FE15D8DA8Q36644697-E031D6DE-9B59-4E0E-8808-5E07AC5DF7B5Q36645449-FD6DE1B7-EE25-47AB-B879-8B2194A9BFCFQ40724062-3579F0B1-D2F7-4173-8A0D-BDB90D7D0780
P2860
Influence of carbohydrate moieties on the immunogenicity of human immunodeficiency virus type 1 recombinant gp160.
description
1992 nî lūn-bûn
@nan
1992 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@ast
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@en
type
label
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@ast
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@en
prefLabel
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@ast
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@en
P2093
P2860
P1433
P1476
Influence of carbohydrate moie ...... irus type 1 recombinant gp160.
@en
P2093
Bahraoui E
Benjouad A
Gluckman JC
P2860
P304
P407
P577
1992-04-01T00:00:00Z